Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.2M Buy
11,218
+2,988
+36% +$362K 0.06% 170
2026
Q1
$1.35M Sell
8,230
-5,011
-38% -$770K 0.09% 134
2025
Q4
$2.3M Buy
13,241
+2,174
+20% +$397K 0.09% 218
2025
Q3
$1.59M Sell
11,067
-12,494
-53% -$1.53M 0.06% 268
2025
Q2
$2.37M Sell
23,561
-2,592
-10% -$198K 0.09% 215
2025
Q1
$2M Sell
26,153
-16,640
-39% -$1.27M 0.08% 228
2024
Q4
$2.95M Buy
+42,793
New +$3.08M 0.11% 176

Other funds holding INSM

F/M Investments's INSM Position: Q2 2026 in Review

F/M Investments increased its Insmed (INSM) stake by 36% in Q2 2026, buying an estimated $362K and bringing the position to 11,218 shares worth $1.2M. The position accounts for 0.06% of the portfolio, ranked #170.

F/M Investments first reported a position in INSM in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.95M in Q4 2024. 664 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • F/M Investments held 11,218 shares of Insmed worth $1.2M as of Q2 2026.
  • F/M Investments bought 2,988 Insmed shares in Q2 2026, an estimated $362K.
  • Insmed made up 0.06% of F/M Investments's portfolio in Q2 2026, its #170 holding.
  • F/M Investments first reported a position in Insmed in Q4 2024 and has held it in 7 quarters since.
  • F/M Investments's Insmed position peaked at $2.95M in Q4 2024.
  • 664 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on F/M Investments's 13F filing for Q2 2026, filed 5 Aug 2026.